Gabriella Tikellis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gabriella Tikellis has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Anne Elizabeth Holland
Respiratory Research@Alfred, Monash University, Melbourne, Australia; Physiotherapy, Alfred Health, Melbourne, Australia; Institute for Breathing and Sleep, Melbourne, Australia
8 shared publications - Ian Glaspole
Central Clinical School Monash University Melbourne Victoria Australia
4 shared publications Anne E Holland
Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, Australia; Institute for Breathing and Sleep, Melbourne, Australia; Department of Physiotherapy, Alfred Health, Melbourne, Australia
3 shared publications- Anne-Louise Ponsonby
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia
3 shared publications - Joanna Y. T. Lee
Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, Australia
3 shared publications Karen Symons
Department of Respiratory and Sleep Medicine, Alfred Health, Melbourne, Australia
3 shared publications
Latest Publications
- Open Access
- 9 October 2025
- Published by Elsevier in Respiratory Medicine and Research
- Vol. 88, 101217
Addressing the inequities in interstitial lung disease care outside specialised centres in Australia
- 9 October 2025
- Published by Elsevier in Respiratory Medicine and Research
- Vol. 88, 101217
Open AccessAddressing the inequities in interstitial lung disease care outside specialised centres in Australia
Top 10 research priorities for pulmonary fibrosis in Australia: an update
In 2019, we published the top 10 research priorities for pulmonary fibrosis (PF) as identified by people living with PF, carers and healthcare professionals. Five years on, we report on the updated research priorities. The study involved an online questionnaire (181 respondents); an in-person workshop (25 participants) to discuss priorities and establish final list for ranking, and a second online questionnaire with 31 research questions for ranking (252 respondents). Preservation of lung health and alleviating symptom burden remained important. New priorities included achieving a rapid diagnosis and developing biomarkers. The updated priorities will guide research efforts to ensure alignment with important needs.
Top 10 research priorities for pulmonary fibrosis in Australia: an update
In 2019, we published the top 10 research priorities for pulmonary fibrosis (PF) as identified by people living with PF, carers and healthcare professionals. Five years on, we report on the updated research priorities. The study involved an online questionnaire (181 respondents); an in-person workshop (25 participants) to discuss priorities and establish final list for ranking, and a second online questionnaire with 31 research questions for ranking (252 respondents). Preservation of lung health and alleviating symptom burden remained important. New priorities included achieving a rapid diagnosis and developing biomarkers. The updated priorities will guide research efforts to ensure alignment with important needs.
- Open Access
- 1 July 2025
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 22
Patient and healthcare professional perspectives on telehealth in the care of interstitial lung disease
Background: While telehealth has been used for specialist care during the COVID-19 pandemic, its benefits and barriers to use for delivering care in interstitial lung disease (ILD) remain unclear. We aimed to explore perspectives of patients and healthcare professionals (HCPs) towards telehealth use in ILD. Method: This qualitative study using semi-structured interviews was undertaken in 18 patients with ILD from a single quaternary ILD centre and 18 HCPs of four different disciplines from various ILD centres around Australia. Interviews were transcribed verbatim and coded by two investigators independently using thematic analysis. Themes were developed by consensus. Results: Patients and HCPs had experienced telehealth via video and telephone, predominantly for teleconsultation and/or telerehabilitation. For patients, benefits included provision of ongoing access to healthcare and significant reduction in travel. Healthcare professionals reported teleconsultations played an important role in patient follow-up rather than at initial contact. Concerns of suboptimal rapport and communication and a lack of physical examination were raised by both groups. Individual patient suitability, improvement in technological platform and support, and improved workflow for clinicians were important factors for utilisation of telehealth. Patients were open to the use of home monitoring devices, however, HCPs felt further research was required prior to clinical implementation. Conclusion: This study highlights positive and negative experiences of telehealth for patients and HCPs in the management of ILD . It also identifies areas for improvement to create a tailored telehealth model for ILD care.
- 1 July 2025
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 22
Open AccessPatient and healthcare professional perspectives on telehealth in the care of interstitial lung disease
Background: While telehealth has been used for specialist care during the COVID-19 pandemic, its benefits and barriers to use for delivering care in interstitial lung disease (ILD) remain unclear. We aimed to explore perspectives of patients and healthcare professionals (HCPs) towards telehealth use in ILD. Method: This qualitative study using semi-structured interviews was undertaken in 18 patients with ILD from a single quaternary ILD centre and 18 HCPs of four different disciplines from various ILD centres around Australia. Interviews were transcribed verbatim and coded by two investigators independently using thematic analysis. Themes were developed by consensus. Results: Patients and HCPs had experienced telehealth via video and telephone, predominantly for teleconsultation and/or telerehabilitation. For patients, benefits included provision of ongoing access to healthcare and significant reduction in travel. Healthcare professionals reported teleconsultations played an important role in patient follow-up rather than at initial contact. Concerns of suboptimal rapport and communication and a lack of physical examination were raised by both groups. Individual patient suitability, improvement in technological platform and support, and improved workflow for clinicians were important factors for utilisation of telehealth. Patients were open to the use of home monitoring devices, however, HCPs felt further research was required prior to clinical implementation. Conclusion: This study highlights positive and negative experiences of telehealth for patients and HCPs in the management of ILD . It also identifies areas for improvement to create a tailored telehealth model for ILD care.
- Open Access
- 6 August 2024
- Published by Elsevier in PEC Innovation
- Vol. 5, 100328
A self-management package for pulmonary fibrosis: A feasibility study
- 6 August 2024
- Published by Elsevier in PEC Innovation
- Vol. 5, 100328
Open AccessA self-management package for pulmonary fibrosis: A feasibility study
- Open Access
- 9 January 2024
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 21
Navigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease
Background: People with interstitial lung disease (ILD) were deemed more vulnerable to the SARS-CoV-2 virus and isolated as a means of reducing risk of infection. This study examined the impact of the pandemic on daily life, psychological wellbeing and access to healthcare and identified approaches undertaken to remain safe. Methods: Four specialist clinics in tertiary centres in Australia (Victoria: two sites; New South Wales: one site; Western Australia: one site) recruited patients with ILD during an 8-week period from March 2021. Semi-structured telephone interviews were conducted with transcripts analysed using principles of grounded theory. Results: Ninety participants were interviewed between April and December 2021. Participants were predominantly female, former smokers with an average age of 66 years. IPF and connective tissue-ILD being the most common subtypes. Five main themes were identified: vulnerability reduced social interaction and isolation, access to healthcare services and support, staying active, emotional and psychological impact. Self-management strategies included staying active both physically and mentally. Discussion: Self-management was key to managing the impact of the pandemic. In combination with advances in technology, implementation of strategies for monitoring wellbeing and support for self-management provides an opportunity to leverage the lessons learnt to ensure a more individualised model of care for people with ILD.
- 9 January 2024
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 21
Open AccessNavigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease
Background: People with interstitial lung disease (ILD) were deemed more vulnerable to the SARS-CoV-2 virus and isolated as a means of reducing risk of infection. This study examined the impact of the pandemic on daily life, psychological wellbeing and access to healthcare and identified approaches undertaken to remain safe. Methods: Four specialist clinics in tertiary centres in Australia (Victoria: two sites; New South Wales: one site; Western Australia: one site) recruited patients with ILD during an 8-week period from March 2021. Semi-structured telephone interviews were conducted with transcripts analysed using principles of grounded theory. Results: Ninety participants were interviewed between April and December 2021. Participants were predominantly female, former smokers with an average age of 66 years. IPF and connective tissue-ILD being the most common subtypes. Five main themes were identified: vulnerability reduced social interaction and isolation, access to healthcare services and support, staying active, emotional and psychological impact. Self-management strategies included staying active both physically and mentally. Discussion: Self-management was key to managing the impact of the pandemic. In combination with advances in technology, implementation of strategies for monitoring wellbeing and support for self-management provides an opportunity to leverage the lessons learnt to ensure a more individualised model of care for people with ILD.
- Open Access
- 23 August 2023
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 32 (169) , 230066
Barriers to and facilitators of the use of oxygen therapy in people living with an interstitial lung disease: a systematic review of qualitative evidence
Background: Oxygen therapy is prescribed to treat hypoxaemia in people with interstitial lung disease (ILD); however, uptake and adherence remain an ongoing challenge. This systematic review aimed to identify the barriers to and facilitators of use of oxygen therapy in people with ILD, caregivers and health professionals.Methods: A systematic search for qualitative literature was undertaken using five electronic databases (MEDLINE, CINAHL, Embase, PsycINFO, PubMed). Qualitative analysis identified themes that were mapped to the Theoretical Domains Framework and the Consolidated Framework for Implementation Research and classified as barriers, facilitators or both.Results: A total of 13 studies were eligible for inclusion. Commonly represented domains were associated with the design of the oxygen delivery system, the associated cost, financing, stigmatisation, the physical environment and the individual needs that acted as barriers to and facilitators of the optimisation of oxygen therapy.Conclusion: Effective implementation of oxygen therapy in ILD requires more robust evidence to strengthen international guidelines, sustainable and equitable funding models, and improved oxygen delivery systems that meet the needs of users. Increased information and support for users will be critical to optimise the uptake and outcomes of this important therapy.
- 23 August 2023
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 32 (169) , 230066
Open AccessBarriers to and facilitators of the use of oxygen therapy in people living with an interstitial lung disease: a systematic review of qualitative evidence
Background: Oxygen therapy is prescribed to treat hypoxaemia in people with interstitial lung disease (ILD); however, uptake and adherence remain an ongoing challenge. This systematic review aimed to identify the barriers to and facilitators of use of oxygen therapy in people with ILD, caregivers and health professionals.Methods: A systematic search for qualitative literature was undertaken using five electronic databases (MEDLINE, CINAHL, Embase, PsycINFO, PubMed). Qualitative analysis identified themes that were mapped to the Theoretical Domains Framework and the Consolidated Framework for Implementation Research and classified as barriers, facilitators or both.Results: A total of 13 studies were eligible for inclusion. Commonly represented domains were associated with the design of the oxygen delivery system, the associated cost, financing, stigmatisation, the physical environment and the individual needs that acted as barriers to and facilitators of the optimisation of oxygen therapy.Conclusion: Effective implementation of oxygen therapy in ILD requires more robust evidence to strengthen international guidelines, sustainable and equitable funding models, and improved oxygen delivery systems that meet the needs of users. Increased information and support for users will be critical to optimise the uptake and outcomes of this important therapy.
- Open Access
- 6 April 2023
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 23 (1) , 1-9
Understanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt?
Introduction: The COVID-19 pandemic resulted in a rapid transformation of health services. This study aimed to understand the experiences of healthcare by people with interstitial lung disease (ILD), to inform future service delivery. Methods: Four specialist clinics in tertiary centres in Australia (Victoria:2 sites; New South Wales: 1 site; Western Australia: 1 site) recruited patients with ILD during an 8-week period from March 2021. Participants completed a COVID-specific questionnaire focused on health-related experiences during 2020. Results: Ninety nine (65% of 153) participants completed the questionnaire. 47% had idiopathic pulmonary fibrosis or connective tissue disease-associated ILD, 62% were female and the average age was 66 years. Whilst 56% rated their overall health in 2020 as the same as months prior, 38% indicated a worsening in health attributed to reduced physical activity and fear of contracting the virus. Access to healthcare professionals was ‘good’ in 61%, and ‘fair-to-poor’ for 37% due to missed respiratory assessments, with telehealth (mainly telephone) being perceived as less effective. 89% had contact with respiratory physicians, 68% with general practitioners, predominantly via telephone, with few video consultations. High satisfaction with care was reported by 78%, with lower satisfaction attributed to delays in assessments, disruption to usual services such as pulmonary rehabilitation, and dissatisfaction with telehealth. Conclusion: People with ILD were generally satisfied with their care during 2020, however reduced access to healthcare professionals was challenging for those experiencing a deterioration in health. Telehealth was largely well received but did not always meet the needs of people with ILD particularly when unwell.
- 6 April 2023
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 23 (1) , 1-9
Open AccessUnderstanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt?
Introduction: The COVID-19 pandemic resulted in a rapid transformation of health services. This study aimed to understand the experiences of healthcare by people with interstitial lung disease (ILD), to inform future service delivery. Methods: Four specialist clinics in tertiary centres in Australia (Victoria:2 sites; New South Wales: 1 site; Western Australia: 1 site) recruited patients with ILD during an 8-week period from March 2021. Participants completed a COVID-specific questionnaire focused on health-related experiences during 2020. Results: Ninety nine (65% of 153) participants completed the questionnaire. 47% had idiopathic pulmonary fibrosis or connective tissue disease-associated ILD, 62% were female and the average age was 66 years. Whilst 56% rated their overall health in 2020 as the same as months prior, 38% indicated a worsening in health attributed to reduced physical activity and fear of contracting the virus. Access to healthcare professionals was ‘good’ in 61%, and ‘fair-to-poor’ for 37% due to missed respiratory assessments, with telehealth (mainly telephone) being perceived as less effective. 89% had contact with respiratory physicians, 68% with general practitioners, predominantly via telephone, with few video consultations. High satisfaction with care was reported by 78%, with lower satisfaction attributed to delays in assessments, disruption to usual services such as pulmonary rehabilitation, and dissatisfaction with telehealth. Conclusion: People with ILD were generally satisfied with their care during 2020, however reduced access to healthcare professionals was challenging for those experiencing a deterioration in health. Telehealth was largely well received but did not always meet the needs of people with ILD particularly when unwell.
- 1 April 2022
- Published by Elsevier in Patient Education and Counseling
- Vol. 105 (4) , 956-964
Self-management for pulmonary fibrosis: Insights from people living with the disease and healthcare professionals
- 1 April 2022
- Published by Elsevier in Patient Education and Counseling
- Vol. 105 (4) , 956-964
Self-management for pulmonary fibrosis: Insights from people living with the disease and healthcare professionals
- 15 November 2021
- Published by Wiley in Respirology
- Vol. 27 (1) , 76-84
Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia
Background and objective: In Australia, little is known about delivery of care for people with idiopathic pulmonary fibrosis (IPF). This study examined the organization of IPF care across Australia, how it aligns with guidance for best practice, and identified barriers and facilitators to best care.Methods: Data on the organization of IPF care in Australia were collected from public hospitals using a study‐specific questionnaire between February and July 2020. Semi‐structured telephone interviews were conducted with respiratory physicians from around Australia between April and December 2020. Interviews were transcribed verbatim and thematic analysis was undertaken.Results: Almost all hospitals (n = 38, 97%) held multidisciplinary meetings (MDMs) for diagnosing IPF, with 90% of multidisciplinary teams including expert respiratory physicians and radiologists; however, rheumatologists, interstitial lung disease nurses and a histopathologist were often not available. More than 90% of institutions had access to oxygen therapy, pulmonary rehabilitation and advanced care planning, but access to psychological support and clinical trials was limited (53% and 58%, respectively). Fifteen respiratory physicians (27% regional) were interviewed. Approaches to diagnosis, treatment and access to referral services were generally consistent with best practice guidance; however, regional respondents reported barriers related to inadequate staffing, lack of a nurse coordinator, inadequate access to clinical trials and funding models. Telehealth technologies were perceived as facilitators to best care.Conclusion: Clinical management of IPF in Australia generally aligns with best practice guidance, but there may be some inequity of access to specialist services, particularly in regional areas, that should be addressed to ensure optimal care for all.
- 15 November 2021
- Published by Wiley in Respirology
- Vol. 27 (1) , 76-84
Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia
Background and objective: In Australia, little is known about delivery of care for people with idiopathic pulmonary fibrosis (IPF). This study examined the organization of IPF care across Australia, how it aligns with guidance for best practice, and identified barriers and facilitators to best care.Methods: Data on the organization of IPF care in Australia were collected from public hospitals using a study‐specific questionnaire between February and July 2020. Semi‐structured telephone interviews were conducted with respiratory physicians from around Australia between April and December 2020. Interviews were transcribed verbatim and thematic analysis was undertaken.Results: Almost all hospitals (n = 38, 97%) held multidisciplinary meetings (MDMs) for diagnosing IPF, with 90% of multidisciplinary teams including expert respiratory physicians and radiologists; however, rheumatologists, interstitial lung disease nurses and a histopathologist were often not available. More than 90% of institutions had access to oxygen therapy, pulmonary rehabilitation and advanced care planning, but access to psychological support and clinical trials was limited (53% and 58%, respectively). Fifteen respiratory physicians (27% regional) were interviewed. Approaches to diagnosis, treatment and access to referral services were generally consistent with best practice guidance; however, regional respondents reported barriers related to inadequate staffing, lack of a nurse coordinator, inadequate access to clinical trials and funding models. Telehealth technologies were perceived as facilitators to best care.Conclusion: Clinical management of IPF in Australia generally aligns with best practice guidance, but there may be some inequity of access to specialist services, particularly in regional areas, that should be addressed to ensure optimal care for all.
- Open Access
- 1 October 2020
- Published by Elsevier in Environment International
- Vol. 143, 105955
Residential proximity to agriculture and risk of childhood leukemia and central nervous system tumors in the Danish national birth cohort
- 1 October 2020
- Published by Elsevier in Environment International
- Vol. 143, 105955
Open AccessResidential proximity to agriculture and risk of childhood leukemia and central nervous system tumors in the Danish national birth cohort